Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Oncoimmunology|January 9, 2018
Assessment of neuronal autoantibodies in patients with small cell lung cancer treated with chemotherapy with or without ipilimumabM Hardy-Werbin, O Arpí, A Taus, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 15, 2018
Paclitaxel with or without trametinib or pazopanib in advanced wild-type BRAF melanoma (PACMEL): a multicentre, open-label, randomised, controlled phase II trialV Urbonas, D Schadendorf, L Zimmer, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|August 24, 2010
Revised UK guidelines for the management of cutaneous melanoma 2010J R Marsden, J A Newton-Bishop, L Burrows, et al.
British Journal of Cancer|July 22, 2004
Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancerA J Clayton, S Danson, S Jolly, et al.
British Journal of Cancer|August 31, 2013
Phase I-II study of plitidepsin and dacarbazine as first-line therapy for advanced melanomaR Plummer, P Lorigan, E Brown, et al.
British Journal of Cancer|February 18, 2011
A phase I study of the safety and tolerability of olaparib (AZD2281, KU0059436) and dacarbazine in patients with advanced solid tumoursO A Khan, M Gore, P Lorigan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2016
Distinct subclonal tumour responses to therapy revealed by circulating cell-free DNAG Gremel, R J Lee, M R Girotti, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|September 4, 2019
Current role of sentinel lymph node biopsy in the management of cutaneous melanoma: A UK consensus statementH Peach, R Board, M Cook, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2005
Phase II study of ET-743 in advanced soft tissue sarcomas: a European Organisation for the Research and Treatment of Cancer (EORTC) soft tissue and bone sarcoma group trialA Le Cesne, J Y Blay, I Judson, et al.
British Journal of Cancer|April 16, 2009
O(6)-methylguanine-DNA methyltransferase depletion and DNA damage in patients with melanoma treated with temozolomide alone or with lomeguatribA J Watson, M R Middleton, G McGown, et al.
Pageof 8